- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 649
Inkbit blots $12m onto its ledger
Five corporates have chipped in for MIT's 3D printing technology developer Inkbit, which hopes to use AI and computer vision to produce complex components at scale.
Nov 8, 2019eGenesis brings about $100m series B
Leaps by Bayer has put $50m into xenotransplantation technology developer eGenesis as part of a $100m series B round that followed a $38m series A backed by Heritage Provider Network.
Nov 8, 2019WealthNavi coordinates $37.6m round
Opt, NEC, Sony, Sumitomo Mitsui Banking Corporation and Mizuho Bank are among a long list of investors that have backed a $37.6m funding round for WealthNavi.
Nov 8, 2019Pops Worldwide entertains $30m idea
Mirae Asset-Naver Asia Growth Fund has contributed to a $30m round for Pops Worldwide, whose existing shareholders include WarnerMedia.
Nov 8, 2019Seismic tremours for Percolate
WPP-backed enterprise content marketing platform developer Percolate has been picked up by Seismic, having previously raised about $107m in funding.
Nov 8, 2019Corporates treat AiCure to $24.5m series C
AiCure has picked up series C capital from investors such as Singtel Innov8 and Asahi Kasei to bolster its commercial, engineering and R&D efforts.
Nov 8, 2019Wrench extracts $20m series C
Wrench operates a mobile vehicle repair service and has added $20m to its coffers thanks to commitment from the likes of Marubeni.
Nov 8, 2019Productiv lines up $20m series B
Okta Ventures supplied a share of the cash for software engagement analytics platform Productiv, which last raised funding in March 2019.
Nov 8, 2019HealthCare.com mends $18m series B
Axis Capital and CNO Financial Group invested in health insurance portal Healthcare.com’s second funding round, proceeds of which will support product development and other growth objectives.
Nov 8, 2019Cadence slips into $15m series A
Mayo Clinic Ventures pumped in a share of the proceeds for Cadence Neuroscience, which is working on biomarker-powered neuromodulation therapies for drug resistant-focal epilepsy.
Nov 8, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


